BSE filing, NSE: TNSTLTU. Summary written from the filing by ALFA Finder's alert engine.
Tamil Nadu Steel Tubes Ltd: key numbers
- Share price
- ₹30.75
- Market cap
- ₹15.76 Cr
- Revenue (annual)
- ₹91.86 Cr
- Net profit (annual)
- ₹0.06 Cr
- P/E (TTM)
- 566.8×Sector 16.9×
- Promoter holding
- 13.61%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Tamil Nadu Steel Tubes Ltd
All →Tamil Nadu Steel Tubes Management Change
Tamilnadu Steel Tubes' Board noted Independent Director Mrs. Divya Abishek's tenure ending 20 Sept 2026. Her resignation letter is attached.
Tamil Nadu Steel Tubes Annual General Meeting
Tamilnadu Steel Tubes filed proceedings of its 47th AGM held 16 Sept 2026. The meeting approved audited financials, director appointments and a borrowing-limit increase.
Tamil Nadu Steel Tubes Annual General Meeting
Tamilnadu Steel Tubes Limited has submitted its Annual Report for 2025-26 and the notice for the 47th Annual General Meeting scheduled on 16.09.2026.
Tamil Nadu Steel Tubes Annual General Meeting
Tamilnadu Steel Tubes Limited will hold its 47th Annual General Meeting on September 16, 2026, via video conference. The company also announced book closure dates.
Tamil Nadu Steel Tubes Q1 FY27 Results: Net Profit ₹2 Cr, Down 60.0% YoY
Tamil Nadu Steel Tubes Ltd reported revenue from operations of ₹2,136 Cr (-14.9% YoY) and net profit of ₹2 Cr (-60.0% YoY) for Q1 FY27.
- Key figure
- Net profit ₹2 Cr · -60.0% YoY
Tamil Nadu Steel Tubes Q1 FY27 Results: Net Profit ₹0 Cr
Tamil Nadu Steel Tubes Ltd reported revenue from operations of ₹21.4 Cr (-14.7% YoY) and net profit of ₹0 Cr for Q1 FY27.
- Key figure
- Net profit ₹0 Cr
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.